Business Wire

Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, ...
Pharmabiz

Recipharm, Medspray & Resyca ink license agreement to develop nasally-delivered drug products using proprietary soft mist technology

Recipharm, a leading contract development and manufacturing organisation (CDMO), announced an exclusive licence and collaboration agreement with Medspray and Resyca, to develop soft mist nasal ...
Yahoo Finance

Cyrano Therapeutics and Resyca Announce Exclusive License Agreement for Soft Mist Nasal Spray Technology for the Treatment of Chemosensory Dysfunction

Soft Mist Nasal Spray Technology Designed to Enhance Drug Deposition in the Olfactory Region, Increasing the Potential for CYR-064's Therapeutic Efficacy DELRAY BEACH, Fla and ENSCHEDE, Netherlands, ...
KXAN

Soft Mist Inhaler Market Inhales Strong Growth Prospects to 2031

JERSEY, NJ, US, April 2, 2024 /EINPresswire.com/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Soft Mist ...
Business Wire

Inhalation and Nasal Spray Generic Drugs Strategic Research Report 2024-2030: Rising Demand for Cost-effective Treatment Options and Combination Inhalers - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Inhalation and Nasal Spray Generic Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Inhalation and ...